PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Jobs
  • Contacts

Russia Plans to Halve Dependence on Imports of Critical Biocomponents by 2030

The strategy for developing the bioeconomy sector предусматривает создание новых рынков, включая синтетическую биологию, промышленную микробиологию, биополимеры, биотопливо и продукты питания нового поколения, сообщил глава Минпромторга Антон Алиханов.

Russia plans to reduce its dependence on imports of critical biotechnological components—such as enzymes, starter cultures, and certain types of protein products—by at least half by 2030. This was stated by Russia’s Minister of Industry and Trade, Anton Alikhanov, in an interview with TASS.

“By 2030, we plan to cut import dependence on critically important biotechnological components—enzymes, starter cultures, and certain protein products—by at least twofold,” the minister said.

In addition, the strategy for the development of the bioeconomy sector aims to create new markets, including synthetic biology, industrial microbiology, biopolymers, biofuels, and next-generation food products, Alikhanov noted.

Another objective is to position Russia among the world’s leading suppliers of high value-added products from deep processing. This will involve expanding non-resource exports and creating new high-tech jobs, the minister added.

The development of the bioeconomy in Russia and the application of biotechnology across economic sectors will be discussed at the Future Technologies Forum, which will take place in Moscow on February 25–26. The main theme of this year’s forum is “Bioeconomy for People.”

Source: TASS, February 10, 2026.

Current news

  • June 3, 2026

    Russia Proposes Clarifying Rules for Using Patented Medicines in Research

    A bill has been submitted to the State Duma that would allow patented medicines to…

  • June 3, 2026

    Regulator Clarifies Rules for Describing Medicines in Public Procurement

    Russia’s Ministry of Health has clarified the rules for describing medicinal products in state and…

  • June 3, 2026

    Ministry of Industry and Trade Prepares New Subsidy Mechanism for Drug Development

    Russia’s Ministry of Industry and Trade has prepared a draft resolution introducing a new procedure…

  • June 3, 2026

    Russian Health Ministry Proposes Major Changes to Pharmaceutical Manufacturing Inspections

    Russia’s Ministry of Health has submitted for public consultation a draft legislative package introducing amendments…

  • June 3, 2026

    Sirius to Launch Master’s Programs in Drug Development

    The programs will be implemented jointly with leading Russian pharmaceutical companies and research centers. Sirius…

LLC “BioJet”. all rights reserved

  • Legal information